SCHEMBL9257929

SCHEMBL9257929

CCCCCCCCCCC(C=O)CCCC

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.70
SMN1; SMN2 Q16637 1/20 0.70
ADH1B P00325 2/20 0.48
ADH1C P00326 2/20 0.48
ADH1A P07327 2/20 0.48
ADH4 P08319 2/20 0.48
ADH7 P40394 2/20 0.48
DNM1 Q05193 2/20 0.46
CA2 P00918 1/20 0.43
MAPT P10636 2/20 0.42
TRPA1 O75762 1/20 0.42
DDAH1 O94760 1/20 0.42
GAPDH P04406 1/20 0.42
FDPS P14324 4/20 0.41
GPR84 Q9NQS5 3/20 0.41
FFAR1 O14842 1/20 0.41
EPHX1 P07099 1/20 0.41
LMNA P02545 1/20 0.41
THRB P10828 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2920547 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL10403846 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL29291467 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL9714408 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL729815 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL29291473 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL2926136 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL28418848 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL10491642 1.00 TSHR (0.70) TSHRSMN1; SMN2ADH1BADH1CADH1A
SCHEMBL7772441 0.98 TSHR (0.67) TSHRSMN1; SMN2ADH1BADH1CADH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US claimed
CN-111481469-B copolymer 宝丽化学工业有限公司 2023-09-19 CN disclosed
CN-111358713-B copolymer 宝丽化学工业有限公司 2023-09-19 CN disclosed
EP-4215188-A1 AN AMINO LIPID, PREPARATION METHOD AND APPLICATION THEREOF Shenzhen MagicRNA Biotechnology Co., Ltd. (CN) 2023-07-26 EP disclosed
CN-111329788-B Copolymer 宝丽化学工业有限公司 2023-03-31 CN disclosed
CN-111329787-B Copolymer 宝丽化学工业有限公司 2023-03-31 CN disclosed
CN-111481469-A Copolymer 宝丽化学工业有限公司 2020-08-04 CN disclosed
CN-111358713-A Copolymer 宝丽化学工业有限公司 2020-07-03 CN disclosed
CN-111329788-A Copolymer 宝丽化学工业有限公司 2020-06-26 CN disclosed
CN-111329787-A Copolymer 宝丽化学工业有限公司 2020-06-26 CN disclosed
CN-1028427-C Rhizoxin derivatives and their use as antitumor agents SANKYO CO (JP) 1995-05-17 CN disclosed
US-5391564-A E.g., rhizoxin-13-yl 3-methylthiopropionate; anticarcinogenic agents SANKYO COMPANY, LIMITED (JP) 1995-02-21 US disclosed
US-5352689-A Rhizoxin derivatives and their use as anti-tumor agents SANKYO COMPANY, LIMITED (JP) 1994-10-04 US disclosed
EP-0350315-B1 RHIZOXIN DERIVATES AND THEIR USE AS ANTI-TUMOR AGENTS SANKYO COMPANY LIMITED (JP) 1993-06-16 EP disclosed
CN-1040982-A Nitragin (rhizoxin) derivative and as antineoplastic agent SANKYO CO (JP) 1990-04-04 CN disclosed
EP-0350315-A1 Rhizoxin derivates and their use as anti-tumor agents SANKYO COMPANY LIMITED (JP) 1990-01-10 EP disclosed